Flagship Ventures Fund Iv General Partner Llc Rubius Therapeutics, Inc. (RUBY) insider trading activity

RUBY Quotes by TradingView

Flagship Ventures Fund IV General Partner LLC Transaction History

Date Transaction Value Shares Traded Form
Mar 19 2021
BUY
Open market or private purchase
$6,090,000 $29.0 p/Share
210,000
Jul 20 2018
BUY
Conversion of derivative security
-
33,296,526

Also insider at

EVLO
Evelo Biosciences, Inc. Healthcare
KLDO
Kaleido Biosciences, Inc. Healthcare
> 10% Shareholder
TMDX
TransMedics Group, Inc. Healthcare
> 10% Shareholder
AXLA
Axcella Health Inc. Healthcare
> 10% Shareholder
MRNA
Moderna, Inc. Healthcare
Director
MCRB
Seres Therapeutics, Inc. Healthcare
> 10% Shareholder
FVF

Flagship Ventures Fund Iv General Partner LLC

> 10% Shareholder
Cambridge, MA

Track Institutional and Insider Activities on RUBY

Follow Rubius Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RUBY shares.

Notify only if

Insider Trading

Get notified when an Rubius Therapeutics, Inc. insider buys or sells RUBY shares.

Notify only if

News

Receive news related to Rubius Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RUBY